World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
18904
World Ranking
2497
National Ranking
19

Medicine

D-Index
72
Citations
21026
World Ranking
19805
National Ranking
230

Overview

Pekka Häyry was affiliated with the University of Helsinki in Finland during their academic career. The available data indicates a focus on research activities primarily connected with this institution.

There are no specific recent papers available to detail, although the record acknowledges a scholarly output without listing titles, years, or venues. Similarly, frequently collaborating co-authors have not been specified, thus no information on academic partnerships is provided.

Details regarding publication venues are also absent, leaving the exact forums for their scholarly communication unknown. The same applies to book publications, with no records on either publishers or titles attributed to their authorship.

The fields of study and subfields connected to Häyry's research are not recorded, and there is no data on the main topics covered in their work. Consequently, the thematic and disciplinary focuses of their scholarship cannot be outlined precisely.

Information about awards received by Pekka Häyry is not documented, including the years or contexts of any recognition, which limits insights into formal acknowledgments or honors they may have attained.

Overall, Pekka Häyry's professional background involves an academic presence linked to a notable Finnish university. The absence of specific data on publications, collaborators, research topics, and honors restricts the scope of this overview to fundamental affiliation details and basic professional status.

Best Publications

  • International standardization of criteria for the histologic diagnosis of renal allograft rejection : the Banff working classification of kidney transplant pathology

    K.i.m. Solez;Roy A. Axelsen;Hallgrimur Benediktsson;James F. Burdick

  • Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

    Lorraine C. Racusen;Robert B. Colvin;Kim Solez;Michael J. Mihatsch

  • A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation

    Paul Keown;Pekka Häyry;Peter Morris;Calvin Stiller

  • The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population

    Jyrki J. Reitamo;Pekka Häyry;Erkki Nykyri;Erkki Saxen

  • PHASE-I CLINICAL TRIAL OF MONOCLONAL ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMOURS

    HenryF. Sears;Jeffrey Mattis;Dorothee Herlyn;Pekka Häyry

  • Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis.

    Karl B. Lemström;Rainer Krebs;Antti I. Nykänen;Jussi M. Tikkanen

  • MORPHOLOGICAL AND FUNCTIONAL CHARACTERIZATION OF ISOLATED EFFECTOR-CELLS RESPONSIBLE FOR HUMAN NATURAL KILLER ACTIVITY TO FETAL FIBROBLASTS AND TO CULTURED-CELL LINE TARGETS

    E. Saksela;T. Timonen;Annamari Ranki;P. Hayry

  • Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets

    Tuomo Timonen;Eero Saksela;Annamari Ranki;Pekka Häyry

  • Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β

    Sari Mäkelä;Hanna Savolainen;Einari Aavik;Marjukka Myllärniemi

  • Histopathological findings in well-functioning, long-term renal allografts.

    Helena M. Isoniemi;Leena Krogerus;Eeva von Willebrand;Eero Taskinen

  • The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior.

    Pekka Häyry;Jyrki J. Reitamo;Saara Tötterman;Dorrit Hopfner-Hallikainen

  • Histological chronic allograft damage index accurately predicts chronic renal allograft rejection.

    Helena Isoniemi;Eero Taskinen;Pekka Häyry

  • CMV infection, class II antigen expression, and human kidney allograft rejection.

    Eeva von Willebrand;Erna Pettersson;Juhani Ahonen;Pekka Häyry

  • Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.

    A Mennander;S Tiisala;J Halttunen;S Yilmaz

  • Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years.

    Alfredo Mota;Manuel Arias;Eero I Taskinen;Timo Paavonen;Timo Paavonen

  • Allograft response in vitro.

    Pekka Hayry;Leif C. Andersson;Stig Nordling;Martti Virolainen

  • Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.

    K B Lemström;J H Bruning;C A Bruggeman;I T Lautenschlager

  • Identification of resting human T and B lymphocytes by acid alpha-naphthyl acetate esterase staining combined with rosette formation with Staphylococcus aureus strain Cowan 1.

    A. Ranki;T. H. Tötterman;P. Häyry

  • Characterization of surface glycoproteins of mouse lymphoid cells.

    Carl C. Gahmberg;Pekka Häyry;Leif C. Andersson

  • Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation.

    Marukka Myllärniemi;Lazaro Calderon;Karl Lemström;Elisabeth Buchdunger

Frequent Co-Authors

Irmeli Lautenschlager
Irmeli Lautenschlager University of Helsinki
Risto Renkonen
Risto Renkonen University of Helsinki
Leif C. Andersson
Leif C. Andersson University of Helsinki
Cathrien A. Bruggeman
Cathrien A. Bruggeman Maastricht University Medical Centre
Annamari Ranki
Annamari Ranki University of Helsinki
Markku S. Nieminen
Markku S. Nieminen University of Helsinki
Tapani Ruutu
Tapani Ruutu University of Helsinki
Yrjö T. Konttinen
Yrjö T. Konttinen Helsinki University Hospital
Philip F. Halloran
Philip F. Halloran University of Alberta
Veli-Pekka Lehto
Veli-Pekka Lehto University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, expanding your education with related online nursing degrees can open diverse career pathways. Many professionals look to bridge programs to specialize further. For example, an fnp to acnp bridge program online allows Family Nurse Practitioners (FNPs) to transition into acute care roles, gaining advanced expertise that complements immunological research and patient care.

Accelerated study options also appeal to those eager to advance quickly. An accelerated fnp program offers an efficient pathway for registered nurses to become certified FNPs, equipping them with valuable clinical skills relevant to immune system-related health conditions.

For individuals starting without a nursing background, the best online bsn programs for non nurses provide foundational knowledge and credentials essential for entering healthcare fields that intersect with immunological science.

Understanding earning potential is crucial when planning your career. Reviewing insights on how much do dnps make can help you make informed decisions about advancing to a Doctor of Nursing Practice (DNP) degree, often linked to higher salaries and leadership roles in healthcare related to immunology.

Best Scientists Citing Pekka Häyry